Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for smoking cessation through reduction
NCT01370356Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing Varenicline Tartrate with Placebo (2 arms). Primary endpoint: Percentage of Participants With Carbon Monoxide (CO) Confirmed 10-Week Continuous Abstinence From Smoking. Started Jul 2011; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01370356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370356.